BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22666793)

  • 21. Differentiated thyroid carcinomas may elude the immune system by B7H1 upregulation.
    Cunha LL; Marcello MA; Morari EC; Nonogaki S; Conte FF; Gerhard R; Soares FA; Vassallo J; Ward LS
    Endocr Relat Cancer; 2013 Feb; 20(1):103-10. PubMed ID: 23193072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical detection of p53 in differentiated, poorly differentiated and undifferentiated carcinomas of the thyroid.
    Soares P; Cameselle-Teijeiro J; Sobrinho-Simões M
    Histopathology; 1994 Mar; 24(3):205-10. PubMed ID: 8200621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulatory T cells in peripheral blood, lymph node, and thyroid tissue in patients with medullary thyroid carcinoma.
    Müller S; Poehnert D; Müller JA; Scheumann GW; Koch M; Lück R
    World J Surg; 2010 Jul; 34(7):1481-7. PubMed ID: 20162276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. E-cadherin gene alterations are rare events in thyroid tumors.
    Soares P; Berx G; van Roy F; Sobrinho-Simões M
    Int J Cancer; 1997 Jan; 70(1):32-8. PubMed ID: 8985087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclin D1 in well differentiated thyroid tumour of uncertain malignant potential.
    Lamba Saini M; Weynand B; Rahier J; Mourad M; Hamoir M; Marbaix E
    Diagn Pathol; 2015 Apr; 10():32. PubMed ID: 25907675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD4/CD8 + T cells, DC subsets, Foxp3, and IDO expression are predictive indictors of gastric cancer prognosis.
    Li F; Sun Y; Huang J; Xu W; Liu J; Yuan Z
    Cancer Med; 2019 Dec; 8(17):7330-7344. PubMed ID: 31631566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytological features of "noninvasive follicular thyroid neoplasm with papillary-like nuclear features" and their correlation with tumor histology.
    Maletta F; Massa F; Torregrossa L; Duregon E; Casadei GP; Basolo F; Tallini G; Volante M; Nikiforov YE; Papotti M
    Hum Pathol; 2016 Aug; 54():134-42. PubMed ID: 27085556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of FoxP3 protein plays a key role in thyroid tumors in children.
    Szylberg Ł; Bodnar M; Harasymczuk J; Marszalek A
    Fetal Pediatr Pathol; 2014 Apr; 33(2):84-91. PubMed ID: 24328999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FoxP3 in papillary thyroid carcinoma induces NIS repression through activation of the TGF-β1/Smad signaling pathway.
    Ma S; Wang Q; Ma X; Wu L; Guo F; Ji H; Liu F; Zhao Y; Qin G
    Tumour Biol; 2016 Jan; 37(1):989-98. PubMed ID: 26264613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increase in tumour-infiltrating lymphocytes with regulatory T cell immunophenotypes and reduced zeta-chain expression in nasopharyngeal carcinoma patients.
    Yip WK; Abdullah MA; Yusoff SM; Seow HF
    Clin Exp Immunol; 2009 Mar; 155(3):412-22. PubMed ID: 19220831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Influence of lymphocitic thyroiditis on prognostic outcome differentiated thyroid carcinoma].
    Filipović A; Paunović I; Vucković Lj
    Acta Chir Iugosl; 2010; 57(2):85-94. PubMed ID: 20954315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigations on the clinical significance of FOXP3 protein expression in cervical oesophageal cancer and the number of FOXP3+ tumour-infiltrating lymphocytes.
    Xia M; Zhao MQ; Wu K; Lin XY; Liu Y; Qin YJ
    J Int Med Res; 2013 Aug; 41(4):1002-8. PubMed ID: 23760912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High intratumoral FOXP3⁺ T regulatory cell (Tregs) density is an independent good prognosticator in nodal negative colorectal cancer.
    Hanke T; Melling N; Simon R; Sauter G; Bokemeyer C; Lebok P; Terracciano LM; Izbicki JR; Marx AH
    Int J Clin Exp Pathol; 2015; 8(7):8227-35. PubMed ID: 26339391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of costimulatory molecules B7-H1, B7-H4 and Foxp3+ Tregs in gastric cancer and its clinical significance.
    Geng Y; Wang H; Lu C; Li Q; Xu B; Jiang J; Wu C
    Int J Clin Oncol; 2015 Apr; 20(2):273-81. PubMed ID: 24804867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive and prognostic factors in locally advanced breast cancer: effect of intratumoral FOXP3+ Tregs.
    Demir L; Yigit S; Ellidokuz H; Erten C; Somali I; Kucukzeybek Y; Alacacioglu A; Cokmert S; Can A; Akyol M; Dirican A; Bayoglu V; Sari AA; Tarhan MO
    Clin Exp Metastasis; 2013 Dec; 30(8):1047-62. PubMed ID: 23836289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical analysis of FoxP3+ regulatory T cells in lower lip squamous cell carcinomas.
    da Cunha FA; Aguiar MC; Souza LB; Pinto LP; Godoy GP; Alves PM; Nonaka CF
    Braz Oral Res; 2016 Dec; 30(1):e130. PubMed ID: 28001240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PAX8 and peroxisome proliferator-activated receptor gamma 1 gene expression status in benign and malignant thyroid tissues.
    Lacroix L; Mian C; Barrier T; Talbot M; Caillou B; Schlumberger M; Bidart JM
    Eur J Endocrinol; 2004 Sep; 151(3):367-74. PubMed ID: 15362967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulatory T cells and their prognostic value in hepatopancreatobiliary tumours.
    Ozgur HH; Ercetin AP; Eliyatkin N; Seren A; Kupelioglu A; Ortac R; Diniz G; Aktas S
    Hepatogastroenterology; 2014 Oct; 61(135):1847-51. PubMed ID: 25713876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA class II expression in well differentiated thyroid carcinoma: correlation with clinicopathological features.
    Knoll MR; Schwab M; Oestreich K; Rumstadt B; Hagmüller E
    J Exp Clin Cancer Res; 1997 Jun; 16(2):177-82. PubMed ID: 9261744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ID Proteins May Reduce Aggressiveness of Thyroid Tumors.
    Amaral LHP; Bufalo NE; Peres KC; Barreto IS; Campos AHJFM; Ward LS
    Endocr Pathol; 2019 Mar; 30(1):24-30. PubMed ID: 30413933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.